Publications by authors named "Benedito A Carneiro"

49Publications

Commentary: GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response.

Front Immunol 2020 19;11:595289. Epub 2020 Oct 19.

Division of Hematology/Oncology, Lifespan Cancer Institute, Warren Alpert Medical School of Brown University, Providence, RI, United States.

View Article and Find Full Text PDF
November 2020

Emerging Subtypes and New Treatments for Castration-Resistant Prostate Cancer.

Am Soc Clin Oncol Educ Book 2020 May;40:e319-e332

University of California, San Francisco, CA.

View Article and Find Full Text PDF
May 2020

Targeting apoptosis in cancer therapy.

Nat Rev Clin Oncol 2020 07 23;17(7):395-417. Epub 2020 Mar 23.

The Warren Alpert Medical School, Brown University, Providence, RI, USA.

View Article and Find Full Text PDF
July 2020

Somatic Gene Mutation in a Nonsyndromic Metastatic Large Cell Calcifying Sertoli Cell Tumor.

J Endocr Soc 2019 Jul 10;3(7):1375-1382. Epub 2019 May 10.

Section on Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland.

View Article and Find Full Text PDF
July 2019

Nivolumab in Metastatic Adrenocortical Carcinoma: Results of a Phase 2 Trial.

J Clin Endocrinol Metab 2019 12;104(12):6193-6200

Developmental Therapeutics Program, Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois.

View Article and Find Full Text PDF
December 2019

Glycogen synthase kinase-3 beta inhibitors as novel cancer treatments and modulators of antitumor immune responses.

Cancer Biol Ther 2019 12;20(8):1047-1056. Epub 2019 Apr 12.

a Lifespan Cancer Institute, Division of Hematology/Oncology , The Warren Alpert Medical School of Brown University , Providence , RI , USA.

View Article and Find Full Text PDF
August 2020

: a novel gene fusion in hepatic angiosarcoma.

Oncotarget 2019 Jan 4;10(2):245-251. Epub 2019 Jan 4.

Division of Hematology-Oncology, Lifespan Cancer Institute, Warren-Alpert Medical School of Brown University, Providence, RI, USA.

View Article and Find Full Text PDF
January 2019

Androgen receptor-independent prostate cancer: an emerging clinical entity.

Cancer Biol Ther 2018 05 2;19(5):347-348. Epub 2018 Feb 2.

a Division of Hematology-Oncology, Lifespan Cancer Institute, The Warren Alpert Medical School of Brown University , Providence , RI , USA.

View Article and Find Full Text PDF
May 2018

Path toward Precision Oncology: Review of Targeted Therapy Studies and Tools to Aid in Defining "Actionability" of a Molecular Lesion and Patient Management Support.

Mol Cancer Ther 2017 Dec;16(12):2645-2655

Developmental Therapeutics Program, Division of Hematology Oncology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

View Article and Find Full Text PDF
December 2017

A comprehensive review of heregulins, HER3, and HER4 as potential therapeutic targets in cancer.

Oncotarget 2017 Oct 13;8(51):89284-89306. Epub 2017 Jun 13.

Developmental Therapeutics Program, Division of Hematology and Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

View Article and Find Full Text PDF
October 2017

Phase I study of veliparib in combination with gemcitabine.

Cancer Chemother Pharmacol 2017 Sep 2;80(3):631-643. Epub 2017 Aug 2.

Cancer Therapeutics Program, University of Pittsburgh Cancer Institute, Hillman Research Pavilion, Room G27E, 5117 Centre Avenue, Pittsburgh, PA, 15213-1863, USA.

View Article and Find Full Text PDF
September 2017

Clinical features, diagnostic challenges, and management strategies in checkpoint inhibitor-related pneumonitis.

Cancer Manag Res 2017 14;9:207-213. Epub 2017 Jun 14.

Developmental Therapeutics Program, Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

View Article and Find Full Text PDF
June 2017

Overcoming immunosuppression in bone metastases.

Crit Rev Oncol Hematol 2017 Sep 12;117:114-127. Epub 2017 May 12.

Developmental Therapeutics Program, Division of Hematology/Oncology, Feinberg School of Medicine, Chicago, USA. Electronic address:

View Article and Find Full Text PDF
September 2017

Wnt/beta-catenin pathway: modulating anticancer immune response.

J Hematol Oncol 2017 05 5;10(1):101. Epub 2017 May 5.

Developmental Therapeutics Program, Division of Hematology/Oncology, Feinberg School of Medicine, Chicago, IL, USA.

View Article and Find Full Text PDF
May 2017

Nodal Signaling as a Developmental Therapeutics Target in Oncology.

Mol Cancer Ther 2017 05;16(5):787-792

Developmental Therapeutics Program, Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine, Olson Pavilion, Chicago, Illinois.

View Article and Find Full Text PDF
May 2017

Targeting Epidermal Growth Factor Receptor in triple negative breast cancer: New discoveries and practical insights for drug development.

Cancer Treat Rev 2017 Feb 5;53:111-119. Epub 2017 Jan 5.

Developmental Therapeutics Program, Division of Hematology/Oncology, Feinberg School of Medicine, Chicago, USA; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, USA.

View Article and Find Full Text PDF
February 2017

Developmental therapeutics for inflammatory breast cancer: Biology and translational directions.

Oncotarget 2017 Feb;8(7):12417-12432

Developmental Therapeutics Program, Division of Hematology/Oncology, Feinberg School of Medicine, Chicago, United States of America.

View Article and Find Full Text PDF
February 2017

Genomic characterization of high-risk non-muscle invasive bladder cancer.

Oncotarget 2016 Nov;7(46):75176-75184

Developmental Therapeutics Program, Division of Hematology/Oncology, Feinberg School of Medicine and Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA.

View Article and Find Full Text PDF
November 2016

FGFR3-TACC3 fusion in solid tumors: mini review.

Oncotarget 2016 08;7(34):55924-55938

Developmental Therapeutics Program, Division of Hematology and Oncology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

View Article and Find Full Text PDF
August 2016

The challenge of developmental therapeutics for adrenocortical carcinoma.

Oncotarget 2016 Jul;7(29):46734-46749

Northwestern Medicine Developmental Therapeutics Institute, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA.

View Article and Find Full Text PDF
July 2016

Spotlight on lenvatinib in the treatment of thyroid cancer: patient selection and perspectives.

Drug Des Devel Ther 2016 29;10:873-84. Epub 2016 Feb 29.

Northwestern Medicine Developmental Therapeutics Institute, Robert H Lurie Comprehensive Cancer Center of Northwestern University, IL, USA; Division of Hematology and Oncology, Feinberg School of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

View Article and Find Full Text PDF
October 2016

FGFR3-TACC3: A novel gene fusion in cervical cancer.

Gynecol Oncol Rep 2015 Aug 18;13:53-6. Epub 2015 Jun 18.

Northwestern Medicine Developmental Therapeutics Institute, Robert H. Lurie Comprehensive Cancer Center of Northwestern University 645 N Michigan Ave Suite 1006 Chicago, IL, 60611, Unites States.

View Article and Find Full Text PDF
August 2015

Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profiling.

Oncotarget 2015 Nov;6(35):37117-34

Northwestern Medicine Developmental Therapeutics Institute, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

View Article and Find Full Text PDF
November 2015

Targeted therapies in advanced differentiated thyroid cancer.

Cancer Treat Rev 2015 Sep 17;41(8):690-8. Epub 2015 Jun 17.

Northwestern Medicine Developmental Therapeutics Institute, Northwestern University, United States; Division of Hematology and Oncology, Feinberg School of Medicine, Northwestern University, United States; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, United States. Electronic address:

View Article and Find Full Text PDF
September 2015

Tyrosine kinase inhibitor therapy in chronic myeloid leukemia: update on key adverse events.

Expert Rev Hematol 2015 Aug 4;8(4):457-79. Epub 2015 May 4.

Northwestern Medicine Developmental Therapeutics Institute, Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.

View Article and Find Full Text PDF
August 2015

Targeting mTOR signaling pathways and related negative feedback loops for the treatment of acute myeloid leukemia.

Cancer Biol Ther 2015 ;16(5):648-56

a Robert H Lurie Comprehensive Cancer Center of Northwestern University ; Chicago , IL , USA.

View Article and Find Full Text PDF
March 2016

Targeted therapy of acute myeloid leukemia.

Expert Rev Anticancer Ther 2015 Apr 26;15(4):399-413. Epub 2015 Jan 26.

Northwestern Developmental Therapeutics Institute, Northwestern University Feinberg School of Medicine, 645 N Michigan Ave. Suite 1006, Chicago, IL 60611, USA.

View Article and Find Full Text PDF
April 2015

Emerging therapeutic targets in bladder cancer.

Cancer Treat Rev 2015 Feb 24;41(2):170-8. Epub 2014 Nov 24.

Northwestern Medicine Developmental Therapeutics Institute, Feinberg School of Medicine, Northwestern University, United States; Division of Hematology and Oncology, Feinberg School of Medicine, Northwestern University, United States; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, United States.

View Article and Find Full Text PDF
February 2015

Phase I trial of fixed dose rate infusion gemcitabine with gefitinib in patients with pancreatic carcinoma.

Cancer Invest 2007 Aug;25(5):366-71

Department of Medicine, Kellogg Cancer Care Center, Evanston Northwestern Healthcare, Evanston, IL 60201, USA.

View Article and Find Full Text PDF
August 2007

Metastatic basal cell carcinoma: complete response to chemotherapy and associated pure red cell aplasia.

Cancer Invest 2006 Jun-Jul;24(4):396-400

Department of Medicine, Evanston Northwestern Healthcare, Illinois, USA.

View Article and Find Full Text PDF
August 2006

Oxaliplatin-related acute myelogenous leukemia.

Oncologist 2006 Mar;11(3):261-2

Department of Medicine, Kellogg Cancer Care Center, Evanston Northwestern Healthcare, Evanston, Illinois 60201, USA.

View Article and Find Full Text PDF
March 2006

Caspase and bid involvement in Clostridium difficile toxin A-induced apoptosis and modulation of toxin A effects by glutamine and alanyl-glutamine in vivo and in vitro.

Infect Immun 2006 Jan;74(1):81-7

Center for Global Health, Division of Infectious Diseases and International Health, University of Virginia, MR4, Lane Road, Room 3148, Charlottesville, VA 22908, USA.

View Article and Find Full Text PDF
January 2006